Toggle Nav
Close
  • Menu
  • Setting

Anti-TNFRSF9/4-1BB/CD137 Antibody (Urelumab)

Catalog No.
F1481
Anti-TNFRSF9/4-1BB/CD137 Antibody (Urelumab)
Grouped product items
SizePriceStock Qty
100ug
$180.00
Ship with 3-5 days
1mg
$540.00
Ship with 3-5 days
5mg
$1,404.00
Ship with 3-5 days
50mg
$4,717.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Urelumab is a humanized IgG4 monoclonal antibody that acts as a CD137 agonist, which can enhance the anti-tumor activity of T cells and natural killer cells and enhance the cytotoxic activity of Rituximab. Urelumab can be used in the study of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and other types of non-Hodgkin lymphoma (NHL).

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145.82 kDa

Shipping

Dry ice

Cas No.

934823-49-1

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

BMS-663513

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

Q07011

Reactivity

Human, Cynomolgus

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG4

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

The purity of Anti-TNFRSF9/4-1BB/CD137 Antibody (Urelumab) is 97.3%, determined by SEC-HPLC.

Target

TNFRSF9 / 4-1BB / CD137

Note

Please avoid freeze-thaw cycles.